Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
UCrest BhdXKLS:0005 EV-to-EBITDA is 33.84 as of Sep. 10, 2026, which is 364% above its 10-year median of 7.29. The stock has 4 warning signs investors should review. Among 515 Healthcare Providers & Services companies, UCrest Bhd ranks worse than 88.16% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, UCrest Bhd's enterprise value is RM39.39 Mil.
UCrest Bhd's EBITDA for the trailing twelve months (TTM) ended in May. 2026 was RM1.16 Mil. Therefore, UCrest Bhd's EV-to-EBITDA for today is 33.84.
The historical rank and industry rank for UCrest Bhd's EV-to-EBITDA or its related term are showing as below:
XKLS:0005'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -586.49 Med: 7.29 Max: 46.43
Current: 33.84
During the past 13 years, the highest EV-to-EBITDA of UCrest Bhd was 46.43. The lowest was -586.49. And the median was 7.29.
XKLS:0005's EV-to-EBITDA is ranked worse than 88.16% of 515
companies
in the Healthcare Providers & Services industry
Industry Median: 10.57
vs XKLS:0005: 33.84
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
UCrest Bhd's share price for today is RM0.065.
UCrest Bhd's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in May. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM0.001.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for UCrest Bhd's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKLS:0005 vs VEEV, BTSG, TEM: EV-to-EBITDA Comparison
For the Health Information Services subindustry, UCrest Bhd's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
UCrest Bhd EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, UCrest Bhd's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where UCrest Bhd's EV-to-EBITDA falls into.
UCrest Bhd's current Enterprise Value is RM39.39 Mil.
UCrest Bhd's EBITDA for the trailing twelve months (TTM) ended in May. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM1.16 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
UCrest Bhd (XKLS:0005) has a EV-to-EBITDA of 33.84 as of Sep. 10, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on UCrest Bhd. This is 364% above median its historical median of 7.29. According to the industry distribution chart, UCrest Bhd ranks #454 out of 515 companies in the Healthcare Providers & Services industry, placing it in the top 88.2%.
Is UCrest Bhd's EV-to-EBITDA too high?
UCrest Bhd's current EV-to-EBITDA of 33.84 is 364% above median its 10-year median of 7.29. The Healthcare Providers & Services industry median EV-to-EBITDA is 10.57. UCrest Bhd's value of 33.84 is 220.2% above this industry median. Based on the distribution chart, UCrest Bhd ranks #454 out of 515 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does UCrest Bhd's EV-to-EBITDA compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, UCrest Bhd ranks #454 out of 515 companies for EV-to-EBITDA. This places UCrest Bhd in the lower half of its industry. The industry median EV-to-EBITDA is 10.57. UCrest Bhd's value of 33.84 is 220.2% above this benchmark. While the company's 10-year median is 7.29 vs. the industry median of 10.57, UCrest Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.57, based on 515 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. UCrest Bhd's current EV-to-EBITDA of 33.84 is 220.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on UCrest Bhd. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. UCrest Bhd's current EV-to-EBITDA is 33.84, which is 364% above median its own 10-year median of 7.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is UCrest Bhd stock overvalued right now?
Based on GuruFocus' analysis, UCrest Bhd (XKLS:0005) is currently considered Modestly Undervalued. The stock's GF Value™ is RM0.08, compared to a current price of RM0.07 — trading 18.8% below its estimated fair value. The current EV-to-EBITDA is 33.84, which is 364% above median its 10-year median of 7.29 and 220.2% above the Healthcare Providers & Services industry median of 10.57. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For UCrest Bhd (XKLS:0005), the current EV-to-EBITDA is 33.84 as of Sep. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
UCrest Bhd is a technology provider company that engages in network design, product development, and software development. The firm provider of Cloud Hospital and mobile health services. The company offers an i-Medic platform for diagnosis, management, and treatment of chronic diseases such as cardiovascular diseases (CVD), cancer, diabetes, hypertension, sleep apnea, stroke rehabilitation, and other diseases.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0005 has been successfully added to your 
